NCT04224337 2025-12-31
Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma
Seoul National University Hospital
Phase 2 Completed
Seoul National University Hospital
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Peking Union Medical College Hospital